ARTICLE | Clinical News

Vitaros alprostadil regulatory update

April 14, 2014 7:00 AM UTC

Apricus said Luxembourg's Ministry Health approved Vitaros alprostadil to treat erectile dysfunction (ED). Vitaros was approved under Europe's decentralized procedure in June 2013, with the Netherlands acting as the reference state. Concerned member states Germany, Ireland, Italy, Sweden, the U.K., France and Belgium have also approved the drug, which is still under review in Spain. Apricus expects its partners to launch the product throughout 2014. The product is a topical prostaglandin E1 (PGE1) cream formulated with Apricus' NexACT transdermal delivery technology. ...